Ozempic Face Pushes Gen X Toward Facelifts Early
Gen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
Choose safe, discreet locations to record seed phrases and minimize exposure. Follow guidelines to reduce theft risk and loss.
10,940 articlesGen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
The GAO is signaling tougher oversight for AI vendors serving the federal government, with new standards on data disc...
SanDisk surged roughly 3,700% in a year, but a broad market pullback and profit-taking have funds trimming positions ...
SpaceX is a private company, and headlines about members congress recently bought stock can be misleading. This guide...
Acting Attorney General faced sharp questions at a Senate confirmation hearing about the fate of the controversial fu...
When a CFO sells a notable chunk of stock, investors want clarity. This article breaks down what CoreWeave's sold com...
Meta CEO Mark Zuckerberg faced lawmakers over under-13 Instagram use and the effectiveness of age checks. The session...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A legendary investor steps back, and a provocative figure—warren buffett's final $373—sparks fresh questions about ma...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
When a stock leads the market after a big index move, investors pay attention. This piece explains why Argan stock to...